EUROAPI is a Europe-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates serving originator and generic pharmaceutical companies worldwide. Headquartered in France, the company was created from Sanofi’s historical API activities and is listed on Euronext Paris. Its operations span both catalog APIs and custom development and manufacturing (CDMO) services across small- and large-molecule modalities.
EUROAPI’s technology portfolio covers complex chemistry and biotechnology, including peptide and oligonucleotide synthesis, prostaglandins, corticosteroids, hormones, opiates, vitamin B12 via fermentation, and other high-value APIs. The company operates GMP-certified production and development sites in Europe, including facilities in France (Elbeuf, Vertolaye), Germany (Frankfurt), Hungary (Budapest), Italy (Brindisi), and the United Kingdom (Haverhill), with quality systems designed to meet major regulatory requirements.